Cancer_bio Profile Banner
Cancer News Profile
Cancer News

@Cancer_bio

Followers
1K
Following
0
Media
3K
Statuses
135K

Track the latest #Cancer news, research, clinical trials, companies and reports. Continuously updated from 500+ news, research publications. BioPortfolio

London
Joined February 2011
Don't wanna be here? Send us removal request.
@Cancer_bio
Cancer News
6 years
Vycellix and Avectas Announce Collaboration to Advance NextGeneration Solutions for the Optimized Manufacture of Cell & Gene Therapies: Vycellix Inc. an immunodiscovery cell & gene therapy company and Avectas Limited a cell engineering technology…
0
1
1
@Cancer_bio
Cancer News
6 years
ENHERTUÂ Approved in Japan for Treatment of Patients with HER2 Positive Unresectable or Metastatic Breast Cancer: Approval based on the pivotal DESTINYBreast01 trial represents third approval ever under the conditional early approval system in Japan and…
0
1
0
@Cancer_bio
Cancer News
6 years
Cold Genesys Announces Name Change to CG Oncology: Name Change Emphasizes Company Vision and Mission to Combat Cancer Cold Genesys Inc. announced today the company is changing its name to CG Oncology Inc. effective immediately. The name change reflects…
0
1
1
@Cancer_bio
Cancer News
6 years
CG Oncology Announces License and Commercialization Agreement with Kissei Pharmaceutical Co. Ltd. for CG0070 in Japan and Other Asian Countries: Kissei Gains Regional License to CG0070 for Japan South Korea Taiwan and Other Asian Countries With the…
0
0
0
@Cancer_bio
Cancer News
6 years
Infinity Receives Fast Track Designation for IPI549 in Combination with the Checkpoint Inhibitor Opdivo for the Treatment of Advanced Urothelial Cancer: Infinity Pharmaceuticals Inc. NASDAQ INFI announced today that the U.S. Food and Drug Administration…
0
2
0
@Cancer_bio
Cancer News
6 years
Oncology units have become Covid19 units and anesthesiology areas are being retrofitted for intensive care as hospitals face the coronavirus pandemic. httpsbuff.ly2vLSZN9Â: Oncology units have become Covid19 units and anesthesiology areas are being…
0
1
0
@Cancer_bio
Cancer News
6 years
Patterns of brain functional connectivity in frontal and temporal lobe epilepsies.: To examine alterations of functional connectivity FC of the brain in patients with frontal and temporal lobe epilepsies.
0
0
0
@Cancer_bio
Cancer News
6 years
Increased Risk of Multiple Spontaneous Vertebral Fractures at Denosumab Discontinuation Must Be Taken Into Account.
0
0
0
@Cancer_bio
Cancer News
6 years
Machine intelligence in healthcareperspectives on trustworthiness explainability usability and transparency: npj Digital Medicine Published online 26 March 2020; doi10.1038s4174602002542Machine Intelligence MI is rapidly becoming an important approach…
0
0
0
@Cancer_bio
Cancer News
6 years
[News] New therapy for children with plexiform neurofibromas: Children with neurofibromatosis type 1 and inoperable plexiform neurofibromas might have durable tumour shrinkage and clinical benefit with selumetinib, according to a phase 2 trial. https://t.co/ncPI9CgZJ7 #Cancer
0
0
0
@Cancer_bio
Cancer News
6 years
IMV to Announce Fourth Quarter and Full Year 2019 Financial and Operational Results and Host Investor Conference Call and Webcast on March 31 2020: IMV Inc. IMV or the Corporation Nasdaq IMV; TSX IMV a clinicalstage biopharmaceutical company pioneering a…
0
1
0
@Cancer_bio
Cancer News
6 years
Rini Shares Challenges in Keeping Up With COVID19 in Oncology: Brian I. Rini MD highlights the Uromigos podcast efforts to educate other oncologists on how COVID19 will shift their practice as well as adapting to changing procedures in clinic to continue…
0
0
1
@Cancer_bio
Cancer News
6 years
A sports medicine office morphs into a coronavirus clinic braced for the onslaught: Oncology units have become Covid19 units and anesthesiology areas are being retrofitted for intensive care as hospitals face the coronavirus pandemic.
0
1
0
@Colorectal_bio
Colorectal Cancer
6 years
VB111 Hits Milestone in Phase III PlatinumResistant Ovarian Cancer Trial: An independent panel determined that the investigational agent VB111 met the interim prespecified efficacy criterion in the phase III OVAL study in patients with platinumresistant…
0
1
1
@Cancer_bio
Cancer News
6 years
PD1 and PDL1 Inhibitors for the Treatment of Kidney Cancer the Role of PDL1 Assay.: Immune checkpoint inhibitors targeting the programmed death receptor ligand 1 PDL1programmed death receptor 1 PD1 pathway represents a drastic change in the treatment…
0
0
0
@Cancer_bio
Cancer News
6 years
Reply to E. GonzalezRodriguez et al.
0
0
0
@Cancer_bio
Cancer News
6 years
The Role of eHealth in the Delivery of Care for Patients with Hematological Cancers A Systematic Literature Review.: Hematological cancer survivors have significant unmet needs. The use of ehealth interventions has been shown to be effective in improving…
0
0
0
@Cancer_bio
Cancer News
6 years
Implementing Decision Coaching for Lung Cancer Screening in the LowDose Computed Tomography Setting.: The uptake of shared decision making SDM for lung cancer screening LCS as required by the Centers for Medicare & Medicaid Services CMS is suboptimal.…
0
0
0
@Cancer_bio
Cancer News
6 years
Brain Training for Kids Adding a Human Touch.: .
0
0
0
@Cancer_bio
Cancer News
6 years
EpiVax Oncology Inc: EpiVax Oncology Inc. is a privatelyheld biotechnology company focusing on developing precision cancer immunotherapies based in New York City NY. Incorporated in 2017 EpiVax Oncology is a spinout of EpiVax Inc. a company founded by…
0
0
0